Latest & greatest articles for otitis media

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on otitis media or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on otitis media and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for otitis media

21. Montelukast versus inhaled mometasone for treatment of otitis media with effusion in children: A randomized controlled trial (PubMed)

Montelukast versus inhaled mometasone for treatment of otitis media with effusion in children: A randomized controlled trial Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate (...) in this issue.To compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.This randomized controlled trial was done on 2- to 6-year-old children attending Koodakan Hospital in Bandar Abbas, southern Iran, in 2014. Patients were divided into three groups of montelukast, mometasone, and control group. Audiometry was done for all patients at baseline and four weeks after treatment. Patients were

Full Text available with Trip Pro

2017 Electronic physician

22. Supplemental Project to Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media

Supplemental Project to Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media Methods Research Report Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media Methods Research Report Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media Prepared for: Agency for Healthcare Research and Quality U.S. Department (...) . Supplemental Project to Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media. Methods Research Report. (Prepared by the Brown University Evidence-based Practice Center under Contract No. 290-2015-00002-I; 290-32004-T). AHRQ Publication No. 17-EHC018-EF. Rockville, MD: Agency for Healthcare Research and Quality. June 2017. www.effectivehealthcare.ahrq.gov/reports/final.cfm. DOI: https://doi.org/10.23970/ AHRQEPCMETH2. ii Preface The Agency for Healthcare

2017 Effective Health Care Program (AHRQ)

23. Tympanostomy tubes in children with otitis media

Tympanostomy tubes in children with otitis media Tympanostomy tubes in children with otitis media Tympanostomy tubes in children with otitis media Steel D, Adam GP, Di M, Halladay C, Pan I, Coppersmith N, Balk EM, Trikalinos TA Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Steel D, Adam GP, Di M, Halladay C, Pan I, Coppersmith N, Balk EM, Trikalinos TA (...) . Tympanostomy tubes in children with otitis media. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 185. 2017 Authors' objectives The objectives for the systematic review are to synthesize information on the effectiveness of tympanostomy tubes (TT) in children with chronic otitis media with effusion and recurrent acute otitis media, summarize the frequency of adverse effects or complications associated with TT placement, synthesize information

2017 Health Technology Assessment (HTA) Database.

24. Tympanostomy Tubes in Children with Otitis Media

Tympanostomy Tubes in Children with Otitis Media Comparative Effectiveness Review Number 185 Tympanostomy Tubes in Children With Otitis Media eComparative Effectiveness Review Number 185 Tympanostomy Tubes in Children With Otitis Media Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00002-I Prepared by: Brown Evidence-based Practice Center Providence, RI Investigators (...) of the report. Persons using assistive technology may not be able to fully access information in this report. For assistance contact EffectiveHealthCare@ahrq.hhs.gov. Suggested citation: Steel D, Adam GP, Di M, Halladay C, Pan I, Coppersmith N, Balk EM, Trikalinos TA. Tympanostomy Tubes in Children With Otitis Media. Comparative Effectiveness Review No. 185. (Prepared by the Brown Evidence-based Practice Center under Contract No. 290-2015-00002-I.) AHRQ Publication No. 17-EHC003-EF. Rockville, MD: Agency

2017 Effective Health Care Program (AHRQ)

25. Sensorineural hearing loss in patients with chronic suppurative otitis media: Is there a significant correlation? (PubMed)

Sensorineural hearing loss in patients with chronic suppurative otitis media: Is there a significant correlation? Hearing loss as a sequel of chronic suppurative otitis media (CSOM) is often conductive, but recent studies have found an additional sensorineural component in these patients, thus demonstrating inner ear damage. The aim of the study was to determine the association between CSOM and sensorineural hearing loss (SNHL) and to assess the influence of patient's age, duration of disease

Full Text available with Trip Pro

2017 Electronic physician

26. Randomised controlled trial: Clinical failure is more common in young children with acute otitis media who receive a short course of antibiotics compared with standard duration

Randomised controlled trial: Clinical failure is more common in young children with acute otitis media who receive a short course of antibiotics compared with standard duration Clinical failure is more common in young children with acute otitis media who receive a short course of antibiotics compared with standard duration | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser (...) otitis media who receive a short course of antibiotics compared with standard duration Article Text Therapeutics/Prevention Randomised controlled trial Clinical failure is more common in young children with acute otitis media who receive a short course of antibiotics compared with standard duration Roderick P Venekamp 1 , Anne G M Schilder 2 Statistics from Altmetric.com Commentary on: Hoberman A , Paradise JL , Rockette HE , et al . Shortened antimicrobial treatment for acute otitis media in young

Full Text available with Trip Pro

2017 Evidence-Based Medicine (Requires free registration)

30. Otitis media with effusion

Otitis media with effusion Otitis media with effusion - NICE CKS Clinical Knowledge Summaries Share Otitis media with effusion: Summary Otitis media with effusion (OME), also known as 'glue ear', is characterized by a collection of fluid within the middle ear space without signs of acute inflammation. OME is the most common cause of hearing impairment in childhood. The hearing loss usually resolves over several weeks or months, but may be more persistent and, if bilateral, may lead (...) to developmental problems. Symptoms of OME vary with time and the age of the child. OME is most common in young children, with the incidence highest in those aged 2 and 5 years. It presents most commonly in the winter months. The exact cause of OME is uncertain, but over 50% of cases are thought to follow an episode of acute otitis media, especially in children under 3 years of age. Persistence of OME may be caused by one or more of the following: Impaired eustachian tube function causing poor aeration

2017 NICE Clinical Knowledge Summaries

31. Antibiotics for acute otitis media in children.

Antibiotics for acute otitis media in children. Acute otitis media is one of the most common infectious diseases diagnosed in children. Antibiotic treatment use remains controversial. This summary aims to evaluate the effectiveness and safety of antibiotics in children with acute otitis media. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified six systematic reviews including 18 randomized trials. We combined the evidence using meta-analysis (...) and generated a summary of findings table following the GRADE approach. We concluded antibiotics reduce pain at 48-72 hours and reduce the risk of tympanic perforations in children with acute otitis media, but they do not reduce late recurrences and increase the risk of side effects (rash, vomiting and diarrhea).

Full Text available with Trip Pro

2016 Medwave

32. Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children. (PubMed)

Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children. Limiting the duration of antimicrobial treatment constitutes a potential strategy to reduce the risk of antimicrobial resistance among children with acute otitis media.We assigned 520 children, 6 to 23 months of age, with acute otitis media to receive amoxicillin-clavulanate either for a standard duration of 10 days or for a reduced duration of 5 days followed by placebo for 5 days. We measured rates of clinical (...) to 23 months of age with acute otitis media, reduced-duration antimicrobial treatment resulted in less favorable outcomes than standard-duration treatment; in addition, neither the rate of adverse events nor the rate of emergence of antimicrobial resistance was lower with the shorter regimen. (Funded by the National Institute of Allergy and Infectious Diseases and the National Center for Research Resources; ClinicalTrials.gov number, NCT01511107 .).

Full Text available with Trip Pro

2016 NEJM

33. Impact of Pediatric Acute Otitis Media on Child and Parental Quality of Life and Associated Productivity Loss in Malaysia: A Prospective Observational Study (PubMed)

Impact of Pediatric Acute Otitis Media on Child and Parental Quality of Life and Associated Productivity Loss in Malaysia: A Prospective Observational Study Acute otitis media (AOM) affects both child and parental quality of life (QoL). Data on QoL associated with AOM in Malaysia is sparse, and the burden of indirect costs have not been previously reported.To determine the effect of pediatric AOM on child and parental QoL in Malaysia and its economic impact (indirect costs).We utilized a set

Full Text available with Trip Pro

2016 Drugs - real world outcomes

34. Xylitol for preventing acute otitis media in children up to 12 years of age. (PubMed)

Xylitol for preventing acute otitis media in children up to 12 years of age. Acute otitis media (AOM) is the most common bacterial infection among young children in the United States. There are limitations and concerns over its treatment with antibiotics and surgery and so effective preventative measures are attractive. A potential preventative measure is xylitol, a natural sugar substitute that reduces the risk of dental decay. Xylitol can reduce the adherence of Streptococcus pneumoniae (S (...) daycare, there is moderate quality evidence that xylitol (in any form) can reduce the risk of AOM from 30% to around 22% compared with the control group (RR 0.75, 95% CI 0.65 to 0.88). Among the reasons for dropouts, there were no significant differences in abdominal discomfort and rash between the xylitol and the control groups. Xylitol was not effective in reducing AOM among healthy children during a respiratory infection (RR 1.13, 95% CI 0.83 to 1.53; moderate quality evidence) or among otitis

Full Text available with Trip Pro

2016 Cochrane

35. Antibiotics for otitis media with effusion in children. (PubMed)

Antibiotics for otitis media with effusion in children. Otitis media with effusion (OME) is characterised by an accumulation of fluid in the middle ear behind an intact tympanic membrane, without the symptoms or signs of acute infection. Since most cases of OME will resolve spontaneously, only children with persistent middle ear effusion and associated hearing loss potentially require treatment. Previous Cochrane reviews have focused on the effectiveness of ventilation tube insertion (...) of ventilation tube insertion (two trials, 121 children) or in tympanic membrane sequelae (one trial, 103 children), while low quality evidence indicated that children treated with antibiotics were less likely to have acute otitis media episodes within four to eight weeks (five trials, 1086 children; NNTB 18) and within six months post-randomisation (two trials, 199 children; NNTB 5). It should, however, be noted that the beneficial effect of oral antibiotics on acute otitis media episodes within four

Full Text available with Trip Pro

2016 Cochrane

36. Otovent nasal balloon for otitis media with effusion

Otovent nasal balloon for otitis media with effusion Oto Otov vent nasal balloon for otitis media with ent nasal balloon for otitis media with effusion effusion Medtech innovation briefing Published: 15 March 2016 nice.org.uk/guidance/mib59 pathways Summary Summary Otovent is a balloon device designed to relieve the symptoms of otitis media with effusion, commonly known as glue ear. An Otovent kit consists of a nose piece and 5 latex balloons that are inflated by blowing through the nose. Four (...) dysfunction associated with glue ear (otitis media with effusion), or after flying, diving or pressure chamber treatment. It would most likely be used in children with glue ear during or after an active observation period following diagnosis, to help avoid the need for surgery. Effectiv Effectiveness and safety eness and safety No relevant evidence was found for the use of Otovent in adults. Four randomised controlled trials involving a total of 565 children showed statistically significant improvements

2016 National Institute for Health and Clinical Excellence - Advice

37. Systematic review: Antibiotics administered for acute otitis media have modest benefits and adverse effects

Systematic review: Antibiotics administered for acute otitis media have modest benefits and adverse effects Antibiotics administered for acute otitis media have modest benefits and adverse effects | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Antibiotics administered for acute otitis media have modest benefits and adverse effects Article Text Therapeutics/Prevention Systematic review Antibiotics administered for acute otitis media have

2016 Evidence-Based Medicine (Requires free registration)

38. Otitis Media with Effusion (OME)

Otitis Media with Effusion (OME) Clinical Practice Guideline: Otitis Media with Effusion (Update) - Richard M. Rosenfeld, Jennifer J. Shin, Seth R. Schwartz, Robyn Coggins, Lisa Gagnon, Jesse M. Hackell, David Hoelting, Lisa L. Hunter, Ann W. Kummer, Spencer C. Payne, Dennis S. Poe, Maria Veling, Peter M. Vila, Sandra A. Walsh, Maureen D. Corrigan, 2016 MENU IN THIS JOURNAL Sign In Institution Society Access Options You can be signed in via any or all of the methods shown below at the same time (...) are not available for this article. For more information view the page. double-click to add/edit rich text ... Please read and accept the and check the box to generate a sharing link. I have read and accept the terms and conditions Share URL copied to clipboard View permissions information for this article Clinical Practice Guideline: Otitis Media with Effusion (Update) .entryAuthor" data-author-container-selector=".NLM_contrib-group"> Show all authors , MD, MPH 1 1Department of Otolaryngology, SUNY Downstate

Full Text available with Trip Pro

2016 American Academy of Otolaryngology - Head and Neck Surgery

39. Purulent acute otitis media in children over 3 months

Purulent acute otitis media in children over 3 months Haute Autorité de Santé - Purulent acute otitis media in children over 3 months Fermer Choose language Accessibility Change contrast : Standards Reinforced icone Chercher icone plus Chercher My account My account Please fill in your email address to retrieve your email alerts subscriptions. Please fill in your email address to retrieve your newsletter subscriptions. You do not have a saved search Sélection No element in selection Services (...) Services Déclarer un événement indésirable grave Comment déclarer les EIGS Etre accrédité par la HAS Médecins exerçant une spécialité «à risques» Déposer une demande d'évaluation d'actes Modalités et procédures Organiser les soins, les parcours Coordination des soins, coopération entre professionnels Rechercher une recommandation, un guide, un médicament Rechercher une recommandation, un médicament, un guide Date : 09 November 2016 Purulent acute otitis media in children over 3 months Practice

2016 HAS Guidelines

40. Purulent acute otitis media in adults

Purulent acute otitis media in adults Haute Autorité de Santé - Purulent acute otitis media in adults Fermer Choose language Accessibility Change contrast : Standards Reinforced icone Chercher icone plus Chercher My account My account Please fill in your email address to retrieve your email alerts subscriptions. Please fill in your email address to retrieve your newsletter subscriptions. You do not have a saved search Sélection No element in selection Services Services Déclarer un événement (...) indésirable grave Comment déclarer les EIGS Etre accrédité par la HAS Médecins exerçant une spécialité «à risques» Déposer une demande d'évaluation d'actes Modalités et procédures Organiser les soins, les parcours Coordination des soins, coopération entre professionnels Rechercher une recommandation, un guide, un médicament Rechercher une recommandation, un médicament, un guide Date : 09 November 2016 Purulent acute otitis media in adults Practice guidelines - Posted on Nov 18 2016 The aim of this memo

2016 HAS Guidelines